The University Hospital of Liverpool Group are committed to advancing cancer care through innovative research. Our ongoing clinical trials aim to discover better treatments, improve patient outcomes, and enhance quality of life for those affected by cancer.

Learn more about our current studies and how they contribute to the fight against cancer.

This is an open-label, 2-part study in participants with advanced solid malignancies and will be conducted at multiple study sites.